Novo Nordisk Net Worth is11.5 12-Month Sales Growth (%)
VN:F [1.9.22_1171]
deserves the money?
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.22_1171]
Would you date ?
Rating: 0.0/5 (0 votes cast)
Company Name: Novo Nordisk A/S

Company Logo: Image:Novo Nordisk.svg

Company Type: Public company Aktieselskab

Traded As: CSE1158/NOVO B, NVO

Foundation: 1923

Location: Bagsværd, Denmark

Key People: Sten Scheibye (Chairman), Lars Rebien Sørensen (President and chief executive officer), Jesper Brandgaard (chief financial officer)

Industry: Pharmaceuticals, health care

Products: Activella, Novolin, , Levemir, NovoSeven

Revenue: Danish krone 60.8 billion (2010)
Operating Income: DKK 18.89 billion (2010)
Net Income: DKK 14.40 billion (2010)
Assets: DKK 61.40 billion (end 2010)
Equity: DKK 36.97 billion (end 2010)
Num Employees: 30,480 (end 2010)
Homepage: [http://www.novonordisk.com/ www.novonordisk.com]

Intl: yes

Novo Nordisk manufactures and markets pharmaceutical products and services and was created in 1989 through a merger of two Danish companies dating back to the 1920s. It produces, in particular, diabetes care equipment and medications. Novo Nordisk is also involved with haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk is researching pulmonary delivery systems for diabetic medications, and in the early stages of research into autoimmune and chronic inflammatory diseases, using technologies such as translational immunology and monoclonal antibodies
Company headquarters are in Denmark, with production facilities in seven countries, and affiliates or offices in 76 countries. It employed approximately 29,000 people globally as of Q4 2009, and marketed its products in 179 countries. It is the largest publicly traded company in the Nordic countries by market capitalization.
Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The company was ranked 25th among 100 best companies to work for in 2010 by Fortune. In January 2012, Novo Nordisk was named as the most sustainable company in the world by the business magazine Corporate Knights.
Novo Nordisk is involved in publicly-funded collaborative research projects with other industrial and academic partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox. The company is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of EFPIA and the European Commission.
Novo Nordisk founded the World Diabetes foundation to save the lives of those affected by diabetes in developing countries and supported a UN resolution to fight diabetes, making diabetes the only other disease alongside HIV / AIDS to have a commitment to combat at a UN level.
Novo Nordisk is developing immunotherapies to combat chronic inflammatory diseases inc

Novo Nordisk Latest News

Novo Nordisk Diabetes Drug Beats Lilly’s Trulicity in Head-to-Head Test

A Novo Nordisk drug candidate for type 2 diabetes beat Eli Lilly’s dulaglutide (Trulicity) in reducing blood sugar and body weight in patients studied in a late-stage clinical trial, the Denmark-based company says. The results could bring strong ...
Posted: August 17, 2017, 2:40 pm

Novo Nordisk diabetes drug succeeds in late-stage trial

Shares in Novo Nordisk (NYSE:NVO) rose nearly 5% yesterday afternoon after the insulin-maker said that its once-weekly diabetes drug, semaglutide, succeeded in lowering glucose levels in a late-stage trial. The 40-week trial enrolled 1,200 patients and ...
Posted: August 17, 2017, 5:52 am

Novo Nordisk's diabetes drug succeeds in key trial

Novo Nordisk logo is seen in Bagsvaerd outside of Copenhagen Thomson Reuters (Reuters) - Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to ...
Posted: August 16, 2017, 6:33 pm

Novo Nordisk's new semaglutide trounces Lilly's scrappy Trulicity in diabetes trial

Novo Nordisk, fighting competition to its key drug Victoza, just posted data on a follow-up drug that gives it a clear edge over archrival Trulicity. The head-to-head trial compared semaglutide, a longer-acting version of the blockbuster Victoza ...
Posted: August 17, 2017, 10:19 pm

Shikiar Asset Management Inc. Sells 7000 Shares of Novo Nordisk A/S (NVO)

Atwood & Palmer Inc sold 44,325 shares as the company's stock rose 15.20% with the market. More notable recent Novo Nordisk A S (ADR) (NYSE:NVO) news were published by: Fool.com which released: "Why Novo Nordisk A/S (ADR) Jumped 10.6% In May" on June 10 ...
Posted: August 18, 2017, 5:30 pm
Related Topics:
How Much Is Novo Nordisk Earnings, How Much Is Novo Nordisk Income, How Much Is Novo Nordisk Net Worth, How Much Is Novo Nordisk Salary, How Much Is Novo Nordisk Worth, Novo Nordisk, Novo Nordisk Age, Novo Nordisk Annual Report, Novo Nordisk Bio, Novo Nordisk Canada, Novo Nordisk Careers, Novo Nordisk Clayton Nc, Novo Nordisk Country, Novo Nordisk Cycling, Novo Nordisk Cycling Team, Novo Nordisk Date Of Birth, Novo Nordisk Diabetes, Novo Nordisk Earnings, Novo Nordisk Ethnicity, Novo Nordisk Foundation, Novo Nordisk Gossips, Novo Nordisk Grants, Novo Nordisk Height, Novo Nordisk History, Novo Nordisk Home Town, Novo Nordisk Images, Novo Nordisk Inc, Novo Nordisk Income, Novo Nordisk Insulin, Novo Nordisk Job, Novo Nordisk Jobs, Novo Nordisk Logo, Novo Nordisk Miami, Novo Nordisk Nationality, Novo Nordisk Net Worth, Novo Nordisk Networth, Novo Nordisk News, Novo Nordisk Partner, Novo Nordisk Patient Assistance Program, Novo Nordisk Patient Istance, Novo Nordisk Paula Deen, Novo Nordisk Pipeline, Novo Nordisk Place Of Birth, Novo Nordisk Products, Novo Nordisk Rumors, Novo Nordisk Salary, Novo Nordisk Seattle, Novo Nordisk Secrets, Novo Nordisk Stock, Novo Nordisk Us, Novo Nordisk Videos, Novo Nordisk Weight, Novo Nordisk Wiki, Who Is Novo Nordisk,